MD

Mark Daris

AB A2 Biotherapeutics: 4 patents #3 of 13Top 25%
AM Amgen: 3 patents #987 of 2,867Top 35%
Overall (All Time): #672,228 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12195513 LILRB1-based chimeric antigen receptor Carl Alexander Kamb, Agnes Eva Hamburger, Breanna Diandreth, Kiran Deshmukh 2025-01-14
12187775 LILRB1-based chimeric antigen receptor Carl Alexander Kamb, Agnes Eva Hamburger, Breanna Diandreth, Kiran Deshmukh 2025-01-07
12037377 LILRB1-based chimeric antigen receptor Carl Alexander Kamb, Agnes Eva Hamburger, Breanna Diandreth, Kiran Deshmukh 2024-07-16
11858983 C-terminal anti-sclerostin antibody variants Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor 2024-01-02
11466079 C-terminal antibody variants Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor 2022-10-11
11254726 LILRB1-based chimeric antigen receptor Carl Alexander Kamb, Agnes Eva Hamburger, Breanna Diandreth, Kiran Deshmukh 2022-02-22
10202616 Promoter and regulatory elements for improved expression of heterologous genes in host cells Jennitte LeAnn Stevens, Chi-Ming Kevin LI, Huanying Ge 2019-02-12